Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyalgia rheumatica and giant cell arteritis.

Peddasomayajula Subrahmanyan1, Bhaskar Dasgupta

  • 1Southend Associate University Hospital NHS Trust, Essex.

British Journal of Hospital Medicine (London, England : 2005)
|May 30, 2006
PubMed
Summary

Polymyalgia rheumatica and giant cell arteritis are common inflammatory conditions in older adults. This review covers diagnosis, complications, and safe management, balancing glucocorticosteroid benefits against long-term risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026
Same author

A conceptual framework for a RA probability score integrating classification criteria and point-of-care ultrasound in early arthritis.

Rheumatology (Oxford, England)·2026
Same author

Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.

The New England journal of medicine·2026
Same author

A national survey report to facilitate rheumatology ultrasound curriculum proposal.

Rheumatology (Oxford, England)·2026
Same author

A Unified, Stratified Approach to the Large Vessel Vasculitis Spectrum and Imaging Implications.

International journal of rheumatic diseases·2026
Same author

Overlapping macrophage immune profiles in polymyalgia rheumatica and giant cell arteritis.

Rheumatology (Oxford, England)·2025

Area of Science:

  • Rheumatology
  • Geriatric Medicine
  • Internal Medicine

Background:

  • Polymyalgia rheumatica and giant cell arteritis are prevalent inflammatory rheumatic diseases in the elderly population.
  • These conditions require careful management due to potential complications and treatment-related risks.

Purpose of the Study:

  • To review the diagnostic approaches for polymyalgia rheumatica and giant cell arteritis.
  • To discuss the complications associated with these diseases and their treatments.
  • To provide guidance on the safe management of these conditions, emphasizing glucocorticosteroid therapy.

Main Methods:

  • Literature review focusing on diagnostic criteria and management strategies.
  • Analysis of disease complications and treatment outcomes.

Related Experiment Videos

  • Evaluation of the risk-benefit profile of glucocorticosteroid therapy in elderly patients.

    • Main Results:

    • Diagnostic challenges and key indicators for polymyalgia rheumatica and giant cell arteritis.
    • Common complications include visual impairment (in GCA) and treatment side effects.
    • Glucocorticosteroids are effective but carry significant long-term risks.

    Conclusions:

    • Accurate diagnosis and prompt treatment are crucial for managing polymyalgia rheumatica and giant cell arteritis.
    • Long-term glucocorticosteroid use necessitates vigilant monitoring to mitigate adverse effects.
    • A balanced approach is essential for optimizing patient outcomes while minimizing treatment-related harm.